Incyte (INCY) Short term Debt (2012 - 2026)

Incyte (INCY) posted Short term Debt of $39.4 million for Q1 2026, down 4.28% on a QoQ basis from $41.1 million in Q4 2025, and down 5.59% year-over-year from $41.7 million in Q1 2025.

Incyte (INCY) Short term Debt (2012 - 2026) Analysis & Trends

Incyte's Short term Debt history runs 14 years deep, the most recent figure standing at $39.4 million for Q1 2026.

  • Quarterly Short term Debt fell 5.59% year-over-year to $39.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.4 million (down 5.59% YoY) and the FY2025 annual result came in at $41.1 million, up 4.86% from the prior year.
  • Short term Debt was $39.4 million for Q1 2026 at Incyte, down from $41.1 million in the prior quarter.
  • Across five years, Short term Debt topped out at $46.8 million in Q2 2025 and bottomed at $34.2 million in Q3 2022.
  • A 5-year average of $39.1 million and a median of $37.9 million in 2022 frame the typical range for Short term Debt.
  • Annual changes were most pronounced in 2022 — Short term Debt dropped 10.55% — and 2025, when it increased 26.07%.
  • Incyte's Short term Debt stood at $36.5 million in 2022, then gained by 5.16% to $38.4 million in 2023, then gained by 2.12% to $39.2 million in 2024, then grew by 4.86% to $41.1 million in 2025, then fell by 4.28% to $39.4 million in 2026.
  • Business Quant data shows INCY's Short term Debt at $39.4 million in Q1 2026, $41.1 million in Q4 2025, and $45.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 39.38 Mn
Dec 31, 2025 41.14 Mn
Sep 30, 2025 45.62 Mn
Jun 30, 2025 46.84 Mn
Mar 31, 2025 41.72 Mn
Dec 31, 2024 39.24 Mn
Sep 30, 2024 40.34 Mn
Jun 30, 2024 37.16 Mn
Mar 31, 2024 37.16 Mn
Dec 31, 2023 38.42 Mn
Sep 30, 2023 36.82 Mn
Jun 30, 2023 37.51 Mn
Mar 31, 2023 37.17 Mn
Dec 31, 2022 36.54 Mn
Sep 30, 2022 34.19 Mn
Jun 30, 2022 36.92 Mn
Mar 31, 2022 37.87 Mn
Dec 31, 2021 37.01 Mn
Sep 30, 2021 38.22 Mn
Jun 30, 2021 39.99 Mn